WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience PeproTech - Your Source for Neuroscience Research Reagents
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (23)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nie, J.
Right arrow Articles by Lewis, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nie, J.
Right arrow Articles by Lewis, D. L.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 15, 2001, 21(22):8758-8764

Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration

Jingjiang Nie and Deborah L. Lewis

Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, Georgia 30912

The CB1 cannabinoid receptor is a constitutively active receptor that can sequester Gi/o-proteins and prevent other Gi/o-coupled receptors from signaling (Bouaboula et al., 1997; Pan et al., 1998; Vasquez and Lewis, 1999). G-protein sequestration occurs because the population of CB1 cannabinoid receptors exists in both an inactive G-protein-precoupled RGGDP state and a constitutively active R*GGTP state. We tested the hypothesis that the distal C-terminal tail acts to prevent G-protein activation. We found that truncation of the distal C-terminal tail of the CB1 receptor (CB1-417) enhanced both the constitutive activity and the ability of the receptor to sequester G-proteins. In addition, we tested the hypothesis that the conserved aspartate (D2.50) in the second transmembrane domain of the CB1 cannabinoid receptor is crucial for constitutive activity and G-protein sequestration. We found that the mutation of aspartate to asparagine (CB1-D164N) abolished G-protein sequestration and constitutive receptor activity without disrupting agonist-stimulated activity. We conclude that the CB1-D164N mutation and the C-terminal truncation shift the population of receptors in opposite directions. The CB1-D164N mutation shifts the receptor into an inactive R state upcoupled from G-proteins, whereas the C-terminal truncation (CB1-417) shifts the receptor into the active R*GGTP state. Thus the distal C-terminal tail acts to constrain the receptor from activating G-proteins, whereas the aspartate (D2.50) in the second transmembrane domain stabilizes the receptor in both the inactive RGGDP state and the active R*GGTP state.

Key words: G-protein-coupled receptors; patch clamp; calcium channels; constitutive activity; receptor states; cannabinoid; tonic activity; C terminal


Copyright © 2001 Society for Neuroscience  0270-6474/01/21228758-07$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Canals and G. Milligan
Constitutive Activity of the Cannabinoid CB1 Receptor Regulates the Function of Co-expressed Mu Opioid Receptors
J. Biol. Chem., April 25, 2008; 283(17): 11424 - 11434.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al.
CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a
Mol. Pharmacol., December 1, 2007; 72(6): 1557 - 1566.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Anavi-Goffer, D. Fleischer, D. P. Hurst, D. L. Lynch, J. Barnett-Norris, S. Shi, D. L. Lewis, S. Mukhopadhyay, A. C. Howlett, P. H. Reggio, et al.
Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms
J. Biol. Chem., August 24, 2007; 282(34): 25100 - 25113.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. A. McDonald, C. M. Henstridge, C. N. Connolly, and A. J. Irving
An Essential Role for Constitutive Endocytosis, but Not Activity, in the Axonal Targeting of the CB1 Cannabinoid Receptor
Mol. Pharmacol., April 1, 2007; 71(4): 976 - 984.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Slominski, P. M. Plonka, A. Pisarchik, J. L. Smart, V. Tolle, J. Wortsman, and M. J. Low
Preservation of Eumelanin Hair Pigmentation in Proopiomelanocortin-Deficient Mice on a Nonagouti (a/a) Genetic Background
Endocrinology, March 1, 2005; 146(3): 1245 - 1253.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
A. L. Ulfers, J. L. McMurry, A. Miller, L. Wang, D. A. Kendall, and D. F. Mierke
Cannabinoid receptor-G protein interactions: G{alpha}i1-bound structures of IC3 and a mutant with altered G protein specificity
Protein Sci., October 1, 2002; 11(10): 2526 - 2531.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-